Back to the Olympics Newsfeed

French Open finalist blames mother’s breast cancer medication for failed drug test

Related Topics: Sara Errani

LONDON (AP) — Former French Open finalist Sara Errani must serve a two-month doping ban after testing positive for the banned substance letrozole in a test taken in February, the International Tennis Federation said on Monday.
Errani blamed contamination from her mother’s breast cancer medication.

“I never took, in my life and during my career, any prohibited substance,” Errani said in a statement. “I am extremely disappointed but at the same time at peace with my conscience and aware I haven’t done anything wrong.”

An adjudication panel ruled that Errani’s fault was “at the lower end of the scale,” but that she should still be banned for two months from Aug.